Table 2 Safety data of BNT162b2 vaccine in children 5 to 11 years.

From: BNT162b2 vaccine induced variant-specific immunity, safety and risk of Omicron breakthrough infection in children aged 5 to 11 years: a cohort study

Side effect

1st dose

2nd dose

p value

Number

%

Number

%

Fever

6

4

17

11.5

0.012

Rash, lip/eye/face swelling

3

2

5

3.4

NS

Pain at injection site

101

67.3

93

62.8

NS

Medical attention

0

0

0

0

NS

Redness/swelling at injection site

18

12

21

14.2

NS

Headache/body ache

29

19.3

22

14.9

NS

Other reactions

15

10

11

7.4

NS

Any side effect

110

73.3

100

67.6

NS

  1. NS not statistically significant.